Tin tức & Cập nhật

Chỉ hiển thị Multimedia
Brolucizumab for neovascular age-related macular degeneration holds up in real world

Brolucizumab for neovascular age-related macular degeneration holds up in real world

30 Sep 2022

The use of brolucizumab for the treatment of patients with neovascular age-related macular degeneration (nAMD) in the real-world setting appears to be effective and safe, consistent with data from pivotal trials, as reported in a study.

30 Sep 2022
SGLT2 inhibitors potentially protective against dry eye disease

SGLT2 inhibitors potentially protective against dry eye disease

29 Sep 2022 bởiJairia Dela Cruz

Type 2 diabetes (T2D) patients on sodium-glucose cotransporter 2 (SGLT2) inhibitors appear to be at lower risk of dry eye disease (DED) compared with their counterparts who are receiving glucagonlike peptide-1 receptor agonists (GLP-1 RAs), as shown in a study.

29 Sep 2022